Interferon-γ drives antitumor immunity in leptomeningeal metastasis: A potential therapeutic strategy.
Publication
, Journal Article
Kurlich, AF; Whitt, G; Hotchkiss, KM; Khasraw, M
Published in: Neuro Oncol
October 1, 2025
Duke Scholars
Published In
Neuro Oncol
DOI
EISSN
1523-5866
Publication Date
October 1, 2025
Volume
27
Issue
10
Start / End Page
2489 / 2491
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kurlich, A. F., Whitt, G., Hotchkiss, K. M., & Khasraw, M. (2025). Interferon-γ drives antitumor immunity in leptomeningeal metastasis: A potential therapeutic strategy. Neuro Oncol, 27(10), 2489–2491. https://doi.org/10.1093/neuonc/noaf166
Kurlich, Andrew F., Grayson Whitt, Kelly M. Hotchkiss, and Mustafa Khasraw. “Interferon-γ drives antitumor immunity in leptomeningeal metastasis: A potential therapeutic strategy.” Neuro Oncol 27, no. 10 (October 1, 2025): 2489–91. https://doi.org/10.1093/neuonc/noaf166.
Kurlich AF, Whitt G, Hotchkiss KM, Khasraw M. Interferon-γ drives antitumor immunity in leptomeningeal metastasis: A potential therapeutic strategy. Neuro Oncol. 2025 Oct 1;27(10):2489–91.
Kurlich, Andrew F., et al. “Interferon-γ drives antitumor immunity in leptomeningeal metastasis: A potential therapeutic strategy.” Neuro Oncol, vol. 27, no. 10, Oct. 2025, pp. 2489–91. Pubmed, doi:10.1093/neuonc/noaf166.
Kurlich AF, Whitt G, Hotchkiss KM, Khasraw M. Interferon-γ drives antitumor immunity in leptomeningeal metastasis: A potential therapeutic strategy. Neuro Oncol. 2025 Oct 1;27(10):2489–2491.
Published In
Neuro Oncol
DOI
EISSN
1523-5866
Publication Date
October 1, 2025
Volume
27
Issue
10
Start / End Page
2489 / 2491
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences